This conclusion was reached based on some observations that circulating FGF21 levels are increased in obesity, with lower FGF21 receptor expression levels on target tissues such as adipose tissue (146, 384). This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.